The Stock Day Podcast Hosts CytoDyn to Discuss The Addition of Dr. Jonah Sacha to their Team

Jul 10, 03:30 PM
The Stock Day Podcast welcomed CytoDyn (CYDY)(“the Company”), a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. CEO and President, Nader Pourhassan, Ph.D., joined Stock Day host Everett Jolly.